Incyte Provides 2026 Net Sales Outlook and Raises Opzelura Guidance
Incyte (INCY) has issued its financial outlook for 2026, projecting net sales to fall between $5.21 billion and $5.30 billion. A key driver of this growth is the upward revision of guidance for Opzelura, which is now expected to generate between $1.10 billion and $1.12 billion in revenue. CEO William Meury emphasized a dual-track strategic focus aimed at diversifying the company's revenue streams. The strategy involves scaling the core business beyond its primary driver, Jakafi, while simultaneously advancing late-stage pipeline assets to ensure long-term growth and mitigate concentration risk.
Tickers: $INCY
Topics: earnings call pipeline development revenue scaling
Read the full article at Seeking Alpha
Part of the story Loar Holdings Raises 2026 Sales Outlook and Provides Strong 2027 Guidance (7 articles)